Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
University of Kansas Strawberry Hill Campus, Kansas City, Kansas University of Kansas Medical Center Emergency Department, Kansas City, Kansas